We are seeking investors to complete Stage II of our study, as stage I has now been completed successfully.

If you are interested in being a part of this ground-breaking research work and in the possibility of a better quality of life for senior members of our society,

Please contact us:

Neu-Age Therapeutics LLC.

Sheron Wylie-Modro CEO

  sheronwm@neuagetherapeutics.com

The intellectual property is wholly owned by Neu-Age Therapeutics and is filed with the US Patent and Trademark Office.